Companies · USAspending parent record
COMPAGNIE MERIEUX ALLIANCE
No confirmed stock ticker. 4 recipient records grouped under this USAspending parent (UEI WG3DJHG5C1C7).
obligated to date on 5 non-competed awards of $1M+ signed FY2024–26
Not recently updated
Obligated to date, not spending in a year. Selected awards only (rule r5-v1): not this company's not-competed share.
5 non-competed ($1M+) · 1 other ($10M+)
Not recently updated
obligated to date: 75N95024F00002, Department of Health and Human Services, signed FY2024
Not recently updated
No confirmed stock ticker, so no member trades are matched to this company.
Federal contract awards in our records
Each row is one prime contract award on USAspending.gov; “USAspending” opens its official page.
What this table covers: every award signed in FY2024–26 that the agency coded “not competed” and that is $1 million or more, plus any award of $10 million or more (rule r5-v1). Smaller competed awards are not in it, so it is not this company’s total federal business and it cannot show a not-competed share. “Obligated to date” is the total committed on the award so far, including later modifications (USAspending, as of Oct 3, 2026), not the amount at any earlier date.
| Signed in | Non-competed awards | Obligated to date | Other awards $10M+ | Obligated to date |
|---|---|---|---|---|
| FY2024 | 3 | $4.6M | 1 | $11.5M |
| FY2025 | 2 | $3.1M | None in this set | — |
| FY2026incomplete | None in this set | — | None in this set | — |
FY2026 is incomplete: the Department of Defense reports contract actions 90 days late, and older awards keep growing through modifications, so these amounts will rise. Source: USAspending.gov, as of Oct 3, 2026.
| Source | ||||||
|---|---|---|---|---|---|---|
| 75N95024F00002Order under IDV 75N95022D00023CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN | ADVANCED BIOSCIENCE LABORATORIES, INC. | Department of Health and Human Services | Mar 11, 2024FY2024 | Full and open competition | $11,506,045 | USAspending |
| W911SR24F0039Order under IDV W911SR23D0053THE OBJECTIVE OF THIS TASK IS TO UPDATE THE NEXT GENERATION DIAGNOSTICS SYSTEM INCREMENT 1 DEPLOYABLE COMPONENT SECURITY CLASSIFICATION GUIDE. | BIOFIRE DEFENSE LLC | Department of Defense | Mar 29, 2024FY2024 | Not competedOnly one source-other (FAR 6.302-1 other) | $1,953,524 | USAspending |
| HT001424P0239MOLECULAR DIAGNOSTICS KITS | BIOFIRE DEFENSE LLC | Department of Defense | Sep 28, 2024FY2024 | Not competed under SAPSAP non-competition (FAR 13) | $1,540,405 | USAspending |
| 36C24825N0333Order under IDV 36C24825D0014MOLECULAR PATHOGEN DETECTION | BIOMERIEUX INC | Department of Veterans Affairs | Jan 14, 2025FY2025 | Not competedOnly one source-other (FAR 6.302-1 other) | $1,539,190 | USAspending |
| HT940625P0027MOLECULALR ASSAY ANALYZER | BIOFIRE DEFENSE LLC | Department of Defense | Apr 14, 2025FY2025 | Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i)) | $1,538,009 | USAspending |
| 36C26224P0018TISSUE TRACKER SOFTWARE | BIOFIRE DIAGNOSTICS LLC | Department of Veterans Affairs | Oct 1, 2023FY2024 | Not competedUrgency (FAR 6.302-2) | $1,126,211 | USAspending |
FY2024–26 awards to COMPAGNIE MERIEUX ALLIANCE, largest first (obligated to date)
- 75N95024F00002Order under IDV 75N95022D00023CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAINADVANCED BIOSCIENCE LABORATORIES, INC.
- Signed
- Mar 11, 2024FY2024
- Competition
- Full and open competition
- Obligated to date
- $11,506,045
- W911SR24F0039Order under IDV W911SR23D0053THE OBJECTIVE OF THIS TASK IS TO UPDATE THE NEXT GENERATION DIAGNOSTICS SYSTEM INCREMENT 1 DEPLOYABLE COMPONENT SECURITY CLASSIFICATION GUIDE.BIOFIRE DEFENSE LLC
- Agency
- Department of Defense
- Signed
- Mar 29, 2024FY2024
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $1,953,524
- HT001424P0239MOLECULAR DIAGNOSTICS KITSBIOFIRE DEFENSE LLC
- Agency
- Department of Defense
- Signed
- Sep 28, 2024FY2024
- Competition
- Not competed under SAPSAP non-competition (FAR 13)
- Obligated to date
- $1,540,405
- 36C24825N0333Order under IDV 36C24825D0014MOLECULAR PATHOGEN DETECTIONBIOMERIEUX INC
- Signed
- Jan 14, 2025FY2025
- Competition
- Not competedOnly one source-other (FAR 6.302-1 other)
- Obligated to date
- $1,539,190
- HT940625P0027MOLECULALR ASSAY ANALYZERBIOFIRE DEFENSE LLC
- Agency
- Department of Defense
- Signed
- Apr 14, 2025FY2025
- Competition
- Not competed under SAPAuthorized by statute (FAR 6.302-5(a)(2)(i))
- Obligated to date
- $1,538,009
- 36C26224P0018TISSUE TRACKER SOFTWAREBIOFIRE DIAGNOSTICS LLC
- Signed
- Oct 1, 2023FY2024
- Competition
- Not competedUrgency (FAR 6.302-2)
- Obligated to date
- $1,126,211
Recipient records grouped under this company (4)
USAspending groups recipients by its parent-company field, which has known errors. Check that the recipients below belong to COMPAGNIE MERIEUX ALLIANCE; the stock link below is made per recipient.
- BIOFIRE DEFENSE LLC3 awards · 3 non-competed, $5.0M obligated to date
- BIOMERIEUX INC1 award · 1 non-competed, $1.5M obligated to date
- BIOFIRE DIAGNOSTICS LLC1 award · 1 non-competed, $1.1M obligated to date
- ADVANCED BIOSCIENCE LABORATORIES, INC.1 award
Stock ticker
Links between a federal contract recipient and an SEC-registered company, made by a written rule from SEC filings and USAspending records. Only confirmed links are shown.
No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant.
Members of Congress who reported trading this stock
No confirmed stock ticker: this may be a private company, a subsidiary awaiting review, or not matched to an SEC registrant. Without a confirmed ticker, no trades are matched to this company.
Looking for agency-level shares? See non-competed share by agency.